New integrated in vivo microdialysis-electrochemical device for determination of the neurotransmitter dopamine in rat striatum of freely moving rats

Overoxidation of Intrinsically Conducting Polymers

Intrinsically conducting polymers may undergo significant changes of molecular structure and material properties when exposed to highly oxidizing conditions or very positive electrode potentials, commonly called overoxidation. The type and extent of the changes depend on the experimental conditions and chemical environment. They may proceed already at much lower rates at lower electrode potentials because some of the processes associated with overoxidation are closely related to more or less reversible redox processes employed in electrochemical energy conversion and electrochromism. These changes may be welcome for some applications of these polymers in sensors, extraction, and surface functionalization, but in many cases, the change of properties affects the performance of the material negatively, contributing to material and device degradation. This report presents published examples, experimental observations, and their interpretations in terms of both structural and of material property changes. Options to limit and suppress overoxidation are presented, and useful applications are described extensively.

Electrochemically reduced graphene oxide and gold nanoparticles on an indium tin oxide electrode for voltammetric sensing of dopamine

The authors describe an electrochemical dopamine sensor that is based on the use of electrochemically co-reduced graphene oxide (Er-GO) and gold nanoparticles (AuNPs) on an indium-tin oxide (ITO) electrode. The synergistic effects of Er-GO and Er-AuNPs promote electron transport in the modified ITO. This results in an excellent performance for voltammetric sensing of dopamine (DA). Under the optimum conditions and a typical working potential of -0.05 V (vs. Ag/AgCl), the ITO electrode has a linear response in the 0.02-200 μM DA concentration range and a low detection limit of 15 nM. The sensor also showed a good selectivity over ascorbic acid and uric acid. The feasibility of the method was studied by analyzing DA in cerebrospinal fluid of rats. Graphical abstract Schematic presentation of one-step electrochemical co-reduction of graphene oxide (GO) and gold nanoparticles (AuNPs) on an ITO electrode for voltammetric sensing of dopamine.

Microelectronics-based biosensors dedicated to the detection of neurotransmitters: a review

Dysregulation of neurotransmitters (NTs) in the human body are related to diseases such as Parkinson's and Alzheimer's. The mechanisms of several neurological disorders, such as epilepsy, have been linked to NTs. Because the number of diagnosed cases is increasing, the diagnosis and treatment of such diseases are important. To detect biomolecules including NTs, microtechnology, micro and nanoelectronics have become popular in the form of the miniaturization of medical and clinical devices. They offer high-performance features in terms of sensitivity, as well as low-background noise. In this paper, we review various devices and circuit techniques used for monitoring NTs in vitro and in vivo and compare various methods described in recent publications.

Affinity and enzyme-based biosensors: recent advances and emerging applications in cell analysis and point-of-care testing

The applications of biosensors range from environmental testing and biowarfare agent detection to clinical testing and cell analysis. In recent years, biosensors have become increasingly prevalent in clinical testing and point-of-care testing. This is driven in part by the desire to decrease the cost of health care, to shift some of the analytical tests from centralized facilities to "frontline" physicians and nurses, and to obtain more precise information more quickly about the health status of a patient. This article gives an overview of recent advances in the field of biosensors, focusing on biosensors based on enzymes, aptamers, antibodies, and phages. In addition, this article attempts to describe efforts to apply these biosensors to clinical testing and cell analysis.